Dextromethorphan abuse: Clinical effects and management

Journal of the American Pharmacists Association

Volumn 49, Issue 2, 2009, Pages

  Romanelli, Frank ^a   Smith, Kelly M ^a  

^a University of Kentucky   (United States)

Author keywords

Dextromethorphan; Drug abuse; Drug drug interactions

Indexed keywords

DEXTROMETHORPHAN;

ANIMAL; HUMAN; OPIATE ADDICTION; REVIEW; SUBSTANCE ABUSE;

ANIMALS; DEXTROMETHORPHAN; HUMANS; OPIOID-RELATED DISORDERS; SUBSTANCE ABUSE DETECTION;

EID: 67449104153     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2009.08091     Document Type: Article

References (37)

1. Bem JL, Peck R. Dextromethorphan: an overview of safety issues. Drug Saf. 1992;7:190-9.
2. Karttunen P, Tukiainen H, Silvasti M, Kolonen S. Antitussive effect of dextromethorphan and dextromethorphan salbutamol combination in healthy volunteers with artificially induced cough. Respiration. 1987;52:49-53.
3. Boyer EW. Dextromethorphan abuse. Pediatr Emerg Care. 2004;20:858-63.
4. Rammer L, Holmgren P, Sandler H. Fatal intoxication by dextromethorphan: a report on two cases. Forensic Sci Int. 1988;37:233-6.
5. Banerji S, Anderson IB. Abuse of Coricidin HBP cough & cold tablets: episodes recorded by a poison control center. Am J Health Syst Pharm. 2001;58:1811-4.
6. Levine DA. "Pharming": the abuse of prescription and over-thecounter drugs in teens. Curr Opin Pediatr. 2007;19:270-4.
7. Food and Drug Administration. Drug Abuse Advisory Committee, open session, vol. 1. Washington, DC: U.S. Public Health Service; 1990.
8. Watson W. Toxic Exposure Surveillance System dextromethorphan data. Washington, DC: American Association of Poison Control Centers; 2003.
9. U.S. Food and Drug Administration. FDA warns against abuse of dextromethorphan (DXM). Accessed at www.fda.gov/bbs/topics/ANSWERS/2005/ ANS01360,html, July 8, 2008.
10. Partnership for a Drug-Free America. The Partnership Attitude Tracking Study. Accessed at www.drugfree.org/Files/Full-Teen-Report, July 9, 2008.
11. Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE. Monitoring the Future national results on adolescent drug use: overview of key findings, 2007. NIH publ. no. 08-6418. Bethesda, MD: National Institute on Drug Abuse; 2008.
12. The New Dawn Report. Emergency department visits involving patients with co-occurring disorders. Accessed at www.dmh.ca.gov/mhsoac/docs/Meetings/2008/ Feb/CODSAMSAEDvisitsptswithco-occuringdisorders.pdf, July 9, 2008.
13. Siu A, Drachtman R. Dextromethorphan: a review of N-methyl-daspartate receptor antagonist in the management of pain. CNS Drug Rev. 2007;13:96-106.
14. Weinbroum AA, Rudick V, Paret G, et al. The role of dextromethorphan in pain control. Can J Anaesth. 2000;47:585-96.
15. Bryner JK, Wang UK, Hui JW, et al. Dextromethorphan abuse in adolescence: an increasing trend: 1999-2004. Arch Pediatr Adolesc Med. 2006;160:1217-22.
16. Osterhoudt KC. A Cadillac ride to the emergency department. Pediatr Emerg Care. 2005;21:877-9.
17. GovTrack.us. H.R. 970: Dextromethorphan Distribution Act of 2007: 110th Congress. Accessed at www.govtrack.us/congress/bill.xpd?bill=h110-970, July 11, 2008.
18. Hendrickson RG, Cloutier RL. "Crystal dex": free-base dex-tromethorphan. J Emerg Med. 2007;32:393-6.
19. Cranston JW. Abuse of dextromethorphan. Arch Fam Med. 1999;8:99-100.
20. Centers for Disease Control and Prevention. Infant deaths associated with cough and cold medications-two states, 2005. MMWR Morb Mortal Wkly Rep. 2007;56:1-4.
21. Silvasti M, Krattunen P, Tukiannen H. Pharmacokinetics of dextromethorphan and dextrophan: a single dose comparison of three preparations in human volunteers. Int J Clin Pharmacol Ther. 1987;9:493-7.
22. Schadel M, Wu D, Otton S, et al. Pharmacokinetics of dextromethorphan and metabolites in human: influence of the CYP2D6 phenotype and quinidine inhibition. J Clin Psychopharmacol. 1995;15:263-9.
23. Perault MC, Bouquet S, Bertschy G, et al. Debrisoquine and dextromethorphan phenotyping and antidepressant therapy. Therapie. 1991;46:1-3.
24. Kim HS, Park IS, Park WK. NMDA receptor antagonists enhance 5-HT2 receptor-mediated behavior, head-twitch response, in mice. Life Sci. 1998;63:2305-11.
25. Cranston JW, Yoast R. Abuse of dextromethorphan. Arch Fam Med. 1999;8:99-100.
26. Ng YY, Lin WL, Chen TW, et al. Spurious hyperchloremia and decreased anion gap in a patient with dextromethorphan bromide. Am J Nephrol. 1992;12:268-70.
27. Wolfe TR, Caravati EM. Massive dextromethorphan ingestion and abuse. Am J Emerg Med. 1995;13:174-6.
28. Chyka PA, Erdman AR, Manoguerra AS, et al. Dextromethorphan poisoning: an evidence-based consensus guideline for out-ofhospital management. Clin Toxicol. 2007;45:662-77.
29. Schier J. Avoid unfavorable consequences: dextromethorphan can bring about a false-positive phencyclidine urine drug screen. J Emerg Med. 2000;18:379-81.
30. Storrow AB, Magoon MR, Norton J. The dextromethorphan defense: dextromethorphan and the opioid screen. Acad Emerg Med. 1995;2:791-4.
31. Shaul WL, Wandell M, Robertson WO. Dextromethorphan toxicity: reversal by naloxone. Pediatrics. 1977;59:117-9.
32. Schnieder SM, Michelson EA, Boucek CD, et al. Dextromethorphan poisoning reversed by naloxone. Am J Emerg Med. 1991;9:237-8.
33. Katonia B, Wason S. Dextromethorphan danger. N Engl J Med. 1986;314:993.
34. Navarro A, Perry C, Bobo WV. A case of serotonin syndrome precipitated by abuse of the anticough remedy dextromethorphan in a bipolar patient treated with fluoxetine and lithium. Gen Hosp Psychiatry. 2006;28:78-87.
35. Ziaee V, Hamed EA, Hoshmand A, et al. Side effects of dextromethorphan abuse, a case series. Addict Behav. 2005;1607-13.
36. Hinsberger A, Sharma V, Mazmanian D, et al. Cognitive deterioration from long-term abuse of dextromethorphan: a case report. J Psychiatry Neurosci. 1994;19:375-7.
37. Desai S, Aldea D, Daneels E, et al. Chronic addiction to dextromethorphan cough syrup: a case report. J Am Board Fam Med. 2006;19:320-3.